These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38773799)

  • 1. Correction to: Combating antimicrobial resistance through vaccines in children from low- and middle-income countries-a call for research.
    J Trop Pediatr; 2024 Apr; 70(3):. PubMed ID: 38773799
    [No Abstract]   [Full Text] [Related]  

  • 2. Combating antimicrobial resistance through vaccines in children from low- and middle-income countries-a call for research.
    Gingaras C; Collins E
    J Trop Pediatr; 2024 Apr; 70(3):. PubMed ID: 38622730
    [No Abstract]   [Full Text] [Related]  

  • 3. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.
    Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J
    Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vaccines in combating antimicrobial resistance (AMR) bacteria.
    Alghamdi S
    Saudi J Biol Sci; 2021 Dec; 28(12):7505-7510. PubMed ID: 34867055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoonotic sources and the spread of antimicrobial resistance from the perspective of low and middle-income countries.
    Olaru ID; Walther B; Schaumburg F
    Infect Dis Poverty; 2023 Jun; 12(1):59. PubMed ID: 37316938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries.
    Cata-Preta BO; Santos TM; Mengistu T; Hogan DR; Barros AJD; Victora CG
    Vaccine; 2021 Jul; 39(32):4564-4570. PubMed ID: 33744046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review on Bacterial Vaccines Combating Antimicrobial Resistance in Poultry.
    Islam MS; Rahman MT
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood vaccines and antibiotic use in low- and middle-income countries.
    Lewnard JA; Lo NC; Arinaminpathy N; Frost I; Laxminarayan R
    Nature; 2020 May; 581(7806):94-99. PubMed ID: 32376956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
    Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
    Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance.
    Yemeke T; Chen HH; Ozawa S
    Hum Vaccin Immunother; 2023 Dec; 19(1):2215149. PubMed ID: 37248971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N
    Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Antimicrobial Stewardship Programmes in Low and Middle-Income Countries: A Mixed-Methods Study in Nigerian Hospitals.
    Kpokiri EE; Taylor DG; Smith FJ
    Antibiotics (Basel); 2020 Apr; 9(4):. PubMed ID: 32340387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries.
    Pierce J; Apisarnthanarak A; Schellack N; Cornistein W; Maani AA; Adnan S; Stevens MP
    Int J Infect Dis; 2020 Jul; 96():621-629. PubMed ID: 32505875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving access to affordable vaccines for middle-income countries in the african region.
    Mihigo R; Okeibunor J; Cernuschi T; Petu A; Satoulou A; Zawaira F
    Vaccine; 2019 May; 37(21):2838-2842. PubMed ID: 30979568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Antimicrobial Stewardship in Low- and Middle-Income Countries.
    Gyssens IC; Wertheim HF
    Front Public Health; 2020; 8():617000. PubMed ID: 33344409
    [No Abstract]   [Full Text] [Related]  

  • 16. A snapshot survey of antimicrobial resistance in food-animals in low and middle-income countries.
    Ikhimiukor OO; Okeke IN
    One Health; 2023 Jun; 16():100489. PubMed ID: 36683959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines: An Armament in Combating Antimicrobial Resistance.
    Khan M
    J Coll Physicians Surg Pak; 2021 Mar; 31(3):249-252. PubMed ID: 33775009
    [No Abstract]   [Full Text] [Related]  

  • 18. Addressing cancer care in low- to middle-income countries: a call for sustainable innovations and impactful research.
    Stefan DC; Tang S
    BMC Cancer; 2023 Aug; 23(1):756. PubMed ID: 37582762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.
    Iskandar K; Molinier L; Hallit S; Sartelli M; Hardcastle TC; Haque M; Lugova H; Dhingra S; Sharma P; Islam S; Mohammed I; Naina Mohamed I; Hanna PA; Hajj SE; Jamaluddin NAH; Salameh P; Roques C
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):63. PubMed ID: 33789754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.